REG - Futura Medical PLC - Result of AGM <Origin Href="QuoteRef">FUM.L</Origin>
RNS Number : 4918QFutura Medical PLC17 June 2015For immediate release 17 June 2015
Futura Medical plc
("Futura" or "the Company")
Result of AGM
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, confirms that all resolutions were duly passed at its Annual General Meeting held today.
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
Tel: +44 (0) 1483 685 670
Email to: james.barder@futuramedical.com
N+1 Singer (Nominated Adviser and Broker)
Aubrey Powell / Tom Smale - Corporate Finance
Tel:+44 (0) 20 7496 3000
For media enquiries please contact:
Buchanan
Mark Court / Sophie Cowles / Stephanie Watson
Tel: +44 (0) 20 7466 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
This information is provided by RNSThe company news service from the London Stock ExchangeENDRAGUBONRVBANAAR
Recent news on Futura Medical
See all newsREG - Futura Medical PLC - Positive Eroxon® & Eroxon® “Intense” HUT results
AnnouncementREG - Futura Medical PLC - Formal Grant of US Patent
AnnouncementREG - Futura Medical PLC - Holding(s) in Company
AnnouncementREG - Futura Medical PLC - Holding(s) in Company
AnnouncementREG - Futura Medical PLC - Patent notice of allowance granted for the US
Announcement